BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Deals

Synterys, VistaGen deal

VistaGen partnered with drug discovery services company Synterys to develop stem cell-based drug rescue variants of preclinical products previously discontinued by drug developers due to toxicity issues....

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >